Could cause temporary or reversible harm; serious harm is unlikely.
Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.
| Brand name | LOSARTAN POTASSIUM |
| Generic name | LOSARTAN POTASSIUM |
| Active ingredient(s) | LOSARTAN POTASSIUM |
| Distributed by / for | Strides Pharma Inc. |
| NDC | 64380-933-08 |
| Full product label | Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No. 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram- 603 110, Tamilnadu, India, NDC 64380-933-08 |
| Recalling firm | Strides Pharma Inc. |
| Distribution | Nationwide in the USA. |
| Quantity | 2,700 HDPE Bottles |
| Recall initiated | 2023-06-26 |
| Report date | 2023-07-12 |
| Recall completed | 2024-05-15 |
| Recall number | D-0895-2023 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | East Brunswick NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗